The number of people affected by diabetes is expected to exceed 640 million by 2040.
The International Widefield Imaging Study Group (IWISG)—a physician panel with expertise in retinal imaging—has released recommenda
Deep learning, a type of artificial intelligence, uses algorithms to recognize patterns.
Anti-vascular endothelial growth factor (VEGF) agents—including aflibercept, bevacizumab, and ranibizumab—have ushered in a new era in the treatment of retinal and choroidal neovascularization.
This article was reviewed by Dr. Charles C. Wykoff, MD, PhD
New research has shown that a longer axial length (AL) may prove protective of incident diabetic retinopathy (DR).1
Genetic factors play a key role in the onset and progression of diabetic retinopathy, with 65 genes ifentified with several belonging to signaling pathways.
Tool is empowering patients to understand disease, become more involved in their treatment.
Visual cortical prosthesis intended to create artificial form of useful vision for blind individuals